The introduction of more accurate diagnostic tests for prostate cancer, including multiparametric magnetic resonance imaging [41], increases the need for better understanding of the role of PSA in the early detection of symptomatic prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.